Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics.
Vaccine. 2023 Mar 31;41(14):2317-2319. doi: 10.1016/j.vaccine.2023.02.065. Epub 2023 Mar 2.
Vaccine. 2023.
PMID: 36870878
Free PMC article.
No abstract available.
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries.
Getaneh AM, Li X, Mao Z, Johannesen CK, Barbieri E, van Summeren J, Wang X, Tong S, Baraldi E, Phijffer E, Rizzo C, van Wijhe M, Heikkinen T, Bont L, Willem L, Jit M, Beutels P, Bilcke J; for Respiratory Syncytial Virus Consortium in Europe (RESCEU) investigators.
Getaneh AM, et al.
Vaccine. 2023 Feb 24;41(9):1623-1631. doi: 10.1016/j.vaccine.2023.01.058. Epub 2023 Feb 1.
Vaccine. 2023.
PMID: 36737318
Item in Clipboard
Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.
Hodgson D, Koltai M, Krauer F, Flasche S, Jit M, Atkins KE.
Hodgson D, et al.
Vaccine. 2022 Nov 22;40(49):7151-7157. doi: 10.1016/j.vaccine.2022.10.041. Epub 2022 Oct 31.
Vaccine. 2022.
PMID: 36328884
Free article.
Item in Clipboard
Cite
Cite